New York: US health officials said Thursday they now have evidence of untreated fungi that spread in two hospitals and nursing homes.
The outbreak of “superbug” was reported at Washington, DC, nursing home and in two Dallas Regional Hospitals, disease control centers and prevention reported.
A handful of patients have invasive fungal infections that are resistant to the three main drug classes.
“This is really the first time we started to see the grouping of resistance” where the patient seems to get infection with each other, said CDC Dr.
Meghan Lyman.
Mushrooms, Candida Auris, are dangerous forms that are considered dangerous for hospital patients and nursing homes with serious medical problems.
It’s the most deadly when entering the bloodstream, heart or brain.
Outbreaks in health care facilities have been driven when fungi spread through patient contact or on a contaminated surface.
Health officials have sounded alarm for years about Superbug after seeing an infection where the drug that is commonly used has little effect.
In 2019, the doctor diagnosed three cases in New York which was also resistant to the class of medicine, called Echinocandins, which was considered the last defense line.
In these cases, no evidence of infection has spread from patients to patients – scientists conclude resistance to drugs formed during treatment.
New cases spread, CDC concluded.
In Washington, DC, a group of 101 C.
Auris cases in nursing homes dedicated to very sick patients including three who are resistant to the three types of antifungal drugs.
Cluster 22 in two Dallas regional hospitals including two with the level of resistance.
The facility was not identified.
These cases were seen from January to April.
Of the five people who were fully resistant to treatment, three died – both Texas and one patients in Washington.
Lyman said both ongoing outbreaks and additional infections have been identified since April.
But the additional numbers were not reported.
The investigator reviewed medical records and did not find evidence of previous antifungal use among patients in those groups.
Health officials said it meant they spread from people to people.